Activated natural killer (NK) cells mediate graft-versus-tumor (GVT) effects but inhibit graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation.

被引：0
|
作者：
Murphy, WJ
Tian, Z
Asai, O
Hornung, R
Longo, DL
机构：
[1] NCI,FREDERICK CANC RES & DEV CTR,DES,LAB LEUKOCYTE BIOL,FREDERICK,MD 21701
[2] NCI,FREDERICK CANC RES & DEV CTR,SAIC,BCDP,FREDERICK,MD 21701
[3] NIA,BALTIMORE,MD 21224
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1996年 / 44卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A232 / A232
页数：1
相关论文
共 50 条
  • [21] Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation
    Lu, Sydney X.
    Kappel, Lucy W.
    Charbonneau-Allard, Anne-Marie
    Atallah, Renee
    Holland, Amanda M.
    Turbide, Claire
    Hubbard, Vanessa M.
    Rotolo, Jimmy A.
    Smith, Marsinay
    Suh, David
    King, Christopher
    Rao, Uttam K.
    Yim, Nury
    Bautista, Johanne L.
    Jenq, Robert R.
    Penack, Olaf
    Na, Il-Kang
    Liu, Chen
    Murphy, George
    Alpdogan, Onder
    Blumberg, Richard S.
    Macian, Fernando
    Holmes, Kathryn V.
    Beauchemin, Nicole
    van den Brink, Marcel R. M.
    PLOS ONE, 2011, 6 (07):
  • [22] Linkage analysis of minor histocompatibility genes causing graft-versus-host disease (GVHD) following allogeneic bone marrow transplantation.
    Ohashi, J
    Maruya, E
    Tokunaga, K
    Saji, H
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 431 - 431
  • [23] SIGNIFICANCE OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NAKAMURA, H
    TESHIMA, H
    HIRAOKA, A
    SHIBATA, H
    INOUE, T
    MASAOKA, T
    ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (08): : 1627 - 1633
  • [24] GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    YOSHIKAWA, S
    AKAO, Y
    HIRAIWA, A
    SAO, H
    YAMAUCHI, T
    TAHARA, T
    YOSHIKAWA, H
    MATSUYAMA, K
    KIMURA, S
    KITAYAMA, S
    TANABE, S
    UNO, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1984, 14 : 509 - 518
  • [25] GRAFT-VERSUS-HOST DISEASE IN EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION
    KORNGOLD, R
    SPRENT, J
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1991, 197 (01): : 12 - 18
  • [26] The role of selective depletion of alloreactive donor T cells in graft-versus-host disease after allogeneic bone marrow transplantation.
    Chai, Yihuan
    Qiu, Huiying
    Lv, Hui
    BLOOD, 2006, 108 (11) : 382B - 382B
  • [27] ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC MARROW TRANSPLANTATION
    PARKER, N
    COHEN, T
    NURSING CLINICS OF NORTH AMERICA, 1983, 18 (03) : 569 - 577
  • [28] Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation
    Mullen, CA
    LEUKEMIA & LYMPHOMA, 2002, 43 (03) : 503 - 510
  • [29] Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation
    Kami, M
    Kanda, Y
    Sasaki, M
    Takeda, N
    Tanaka, Y
    Saito, T
    Ogawa, S
    Honda, H
    Chiba, S
    Mitani, K
    Hirai, H
    Yazaki, Y
    BONE MARROW TRANSPLANTATION, 1998, 21 (07) : 721 - 723
  • [30] POOR GRAFT FUNCTION ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION
    PERALVO, J
    BACIGALUPO, A
    PITTALUGA, PA
    OCCHINI, D
    VANLINT, MT
    FRASSONI, F
    NARDELLI, E
    TRASINO, A
    PANTAROTTO, M
    MARMONT, AM
    BONE MARROW TRANSPLANTATION, 1987, 2 (03) : 279 - 285
12345